Materiały źródłowe

• #1 Osteoporosis treatment: Medications can help

  https://www.mayoclinic.org/diseases-conditions/osteoporosis/in-depth/osteoporosis-treatment/art-20046869

  Osteoporosis treatment may involve medicines along with lifestyle change. […] If you’re undergoing osteoporosis treatment, you’re taking a step in the right direction for your bone health. […] Bisphosphonates are often the first choice for osteoporosis treatment. […] Another common osteoporosis medicine is denosumab (Prolia). […] Research shows that there could be a high risk of spinal fractures after stopping denosumab, so it’s important that you take it consistently. […] The risk of developing atypical femoral fracture or osteonecrosis of the jaw tends to increase the longer you take bisphosphonates. […] Estrogen, sometimes paired with progestin, was once commonly used to treat osteoporosis. […] Raloxifene (Evista) mimics estrogen’s beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen. […] Most osteoporosis medicines work by reducing the rate at which your bones break down. […] Bone-building medicines include: Teriparatide (Forteo), Abaloparatide (Tymlos), Romosozumab (Evenity). […] Don’t rely entirely on medicines as the only treatment for your osteoporosis.

• #1 Osteoporosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/osteoporosis/diagnosis-treatment/drc-20351974

  Treatment recommendations are often based on an estimate of your risk of breaking a bone in the next 10 years using information such as the bone density test. If your risk isn’t high, treatment might not include medication and might focus instead on modifying risk factors for bone loss and falls. […] For both men and women at increased risk of broken bones, the most widely prescribed osteoporosis medications are bisphosphonates. […] Compared with bisphosphonates, denosumab (Prolia, Xgeva) produces similar or better bone density results and reduces the chance of all types of breaks. […] Estrogen, especially when started soon after menopause, can help maintain bone density. […] Raloxifene (Evista) mimics estrogen’s beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen.

• #1 Patient education: Osteoporosis prevention and treatment (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/osteoporosis-prevention-and-treatment-beyond-the-basics/print

  People with the highest risk of fracture are the ones most likely to benefit from drug therapy. […] In the United States, the Bone Health and Osteoporosis Foundation (BHOF, formerly the National Osteoporosis Foundation) recommends use of a medication to treat postmenopausal women (and men ≥50 years) with a history of hip or vertebral (spine) fracture or with osteoporosis on bone density testing (T-score ≤-2.5). […] However, some people who do not meet the above criteria may benefit from a medication to prevent fractures. […] Bisphosphonates are medications that slow the breakdown and removal of bone (ie, resorption). They are widely used for the prevention and treatment of osteoporosis in postmenopausal women. […] Alendronate (brand names: Binosto, Fosamax) reduces the risk of vertebral and hip fractures, and it decreases the loss of height associated with vertebral fractures.

• #1 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/patients/treatment

  There are two main types of treatment: anti-resorptive agents reduce bone destruction and therefore preserve bone mineral density (BMD), while anabolic agents stimulate bone formation, thereby increasing BMD. […] Medically approved drug therapies for the treatment of osteoporosis and prevention of fractures include: Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid), Raloxifene and bazedoxifene, Teriparatide and abaloparatide, Denosumab, Romosozumab, Menopausal Hormone Therapy (MHT)*. […] Not all of these drugs are available in every country. […] MHT (oestrogen with or without progestin) is not a primary treatment for osteoporosis but has been shown to increase BMD and lower fracture risk in women after menopause. MHT is only recommended for younger postmenopausal women for the treatment of menopausal symptoms, with no contra-indications to its use, and for a limited period of time of approximately 10 years.

• #1

  https://www.nhs.uk/conditions/osteoporosis/treatment/

  Treating osteoporosis involves treating and preventing fractures, and using medicines to strengthen bones. […] If you’ve been diagnosed with osteoporosis because you’ve had a broken bone, you should still receive treatment to try to reduce your risk of further broken bones. […] A number of different medicines are used to treat osteoporosis (and sometimes osteopenia). […] Bisphosphonates slow the rate that bone is broken down in your body. This maintains bone density and reduces your risk of a broken bone. […] SERMs are medicines that have a similar effect on bone as the hormone oestrogen. They help to maintain bone density and reduce the risk of fracture, particularly of the spine. […] Parathyroid hormone treatments (such as teriparatide) are used to stimulate cells that create new bone.

• #1 Osteoporosis: A Review of Treatment Options

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5768298/

  With regard to older men with osteoporosis, denosumab was also found to be cost-effective when compared with bisphosphonates and teriparatide (Forteo, Lilly). […] In recent years, major therapeutic advances in osteoporosis treatment have been made as scientists gain a greater understanding of bone morphology and the underlying mechanisms causing osteoporosis. […] The goal of pharmacological therapy is to reduce the risk of fractures. […] Medications to treat osteoporosis are categorized as either antiresorptive (i.e., bisphosphonates, estrogen agonist/ antagonists [EAAs], estrogens, calcitonin, and denosumab) or anabolic (i.e., teriparatide). […] Per AACE/ACE guidelines, first-line treatment for most PMO patients at high risk of fracture includes alendronate, risedronate, zoledronic acid, and denosumab.

• #1 Patient education: Osteoporosis prevention and treatment (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/osteoporosis-prevention-and-treatment-beyond-the-basics/print

  A once-yearly dose of zoledronic acid (sample brand name: Reclast) is also an option for the treatment of osteoporosis. […] Risedronate (brand names: Actonel, Atelvia) reduces the risk of both vertebral and hip fractures. […] Raloxifene can be used for the prevention and treatment of osteoporosis in postmenopausal women, although it may be less effective in preventing bone loss than bisphosphonates or estrogen. […] Denosumab (brand name: Prolia) is a medicine that blocks a specific protein involved in the formation of cells that break down bone. Denosumab improves bone mineral density and reduces fracture in postmenopausal women with osteoporosis. […] Anabolic agents are usually only recommended for people with severe osteoporosis. […] Clinical trials suggest that PTH and parathyroid hormone-related protein (PTHrP) are effective in the treatment of osteoporosis in postmenopausal women and in men, and that these drugs are more effective than anti-resorptives. […] Romosozumab (brand name: Evenity) is a medicine that blocks a protein in the body. This protein usually stops new bone from being formed. Blocking the protein allows the body to make new bone. Romosozumab has been shown to decrease vertebral and nonvertebral fractures.

• #1 Building Strong Bones: A Comprehensive Guide to Osteoporosis Treatments: Institute of Spinal Disorders: Orthopedic Spine Surgery

  https://www.instituteofspinaldisorders.com/blog/building-strong-bones-a-comprehensive-guide-to-osteoporosis-treatments

  Alendronate (Fosamax), second-generation bisphosphonate, been seen to be most effective with patient with T-scores less than -2.5 or had vertebral fracture. […] Risedronate (Actonel) reduced the incidence of fractures of spine 41-49% after 3 years. […] Ibandronate(Boniva) is used for prevention and treatment of postmenopausal osteoporosis. […] Denosumab is used in the treatment of postmenopausal women for osteoporosis. […] Treatment with this medication has 68% decrease in new vertebral fractures in 12 months. […] Calcitonin reduces bone resorption and may slow bone loss. […] Teriparatide (Ferteo) treats osteoporosis in postmenopausal women and men who are at high risk of fractures. […] In conclusion, osteoporosis is a common condition that can have a significant impact on a person’s quality of life. While there is no cure for this disease, several treatments are available that can help to slow or even reverse the progression of bone loss. Medications, calcium and vitamin D supplements, exercise, healthy lifestyle choices, and fall prevention strategies can all be effective ways to treat osteoporosis.

• #1 Osteoporosis Treatment & Management: Approach Considerations, Pharmacologic Therapy, Dietary Measures

  https://emedicine.medscape.com/article/330598-treatment

  Alendronate (Fosamax) is approved for the treatment of osteoporosis in men, in postmenopausal women, and in patients with glucocorticoid-induced osteoporosis. […] Risedronate reduced vertebral fractures by 41% and nonvertebral fractures by 39% over 3 years. […] Zoledronic acid (Reclast) is a once-yearly intravenous infusion approved for the treatment of osteoporosis in men, in postmenopausal women, and in patients with glucocorticoid-induced osteoporosis. […] Denosumab (Prolia) is a humanized monoclonal antibody directed against the receptor activator of the nuclear factor-kappa B ligand (RANKL), which is a key mediator of the resorptive phase of bone remodeling. […] Calcitonin salmon (Fortical, Miacalcin) is a hormone that decreases osteoclast activity, thereby impeding postmenopausal bone loss. […] Hormone replacement therapy (HRT) was once considered a first-line therapy for the prevention and treatment of osteoporosis in women. […] Strontium ranelate is approved for the treatment of osteoporosis in some countries in Europe. It reduces the risk of both spine and nonvertebral fractures.

• #1 Osteoporosis Medication and Medication Guidelines

  https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/

  Like any medication, osteoporosis drugs can only work if they are taken exactly as prescribed. […] The important thing is to take your medicine and take it consistently. […] With antiresorptive medicines, the goal of treatment is to prevent further bone loss and reduce the risk of fractures. […] You know the drug is working when your bone density stays the same or improves and you have no additional broken bones. […] Romosozumab-aqqg, Teriparatide and Abaloparatide are the only drugs for osteoporosis that have a defined treatment length. […] When a patient responds well to bisphosphonate therapy, many healthcare providers will consider a “bisphosphonate drug holiday” during which the patient takes a break from treatment. […] At the doses used for osteoporosis, AFF and ONJ are very rare. On the other hand, fragility fractures from osteoporosis are very common.

• #1 Osteoporosis | NHS inform

  https://www.nhsinform.scot/illnesses-and-conditions/muscle-bone-and-joints/conditions-that-can-affect-multiple-parts-of-the-body/osteoporosis/

  Treatment for osteoporosis includes: […] taking medication to strengthen bones. […] If you need treatment, your doctor can suggest the safest and most effective treatment plan for you. […] A number of different medications are used to treat osteoporosis. Your doctor will discuss the treatments available and make sure the medicines are right for you. Bisphosphonates slow down the rate at which bone is broken down in your body. This maintains bone density and reduces the risk of fracture. […] Strontium ranelate appears to have an effect on both the cells that break down bone and the cells that create new bone (osteoblasts). […] SERMs are medications that have a similar effect on bone as the hormone oestrogen. They help to maintain bone density and reduce the risk of fracture, particularly of the spine.

• #1 Osteoporosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/osteoporosis/diagnosis-treatment/drc-20351974

  If you have severe osteoporosis or if the more common treatments for osteoporosis don’t work well enough, your doctor might suggest trying: Teriparatide (Bonsity, Forteo). This powerful drug is similar to parathyroid hormone and stimulates new bone growth. […] After you stop taking any of these bone-building medications, you generally will need to take another osteoporosis drug to maintain the new bone growth. […] What treatments are available, and which do you recommend? […] What side effects might I expect from treatment? […] Are there alternatives to the treatment you’re suggesting?

• #1 Osteoporosis Treatment | Endocrine Society

  https://www.endocrine.org/patient-engagement/endocrine-library/osteoporosis-treatment

  Denosumab is also approved as first-line therapy to treat bone loss, but it is commonly used when patients cannot tolerate other osteoporosis medicines or if other medicines are not working well. […] Raloxifene is approved for preventing and treating osteoporosis in postmenopausal women. […] Teriparatide treatment stimulates new bone formation, rather than preventing bone breakdown. […] Abaloparatide is also a bone-building medication that is given as a daily, self-administered injection under the skin for no more than two years. […] Romosozumab is a bone-building medication that is given once a month as pair of injections by a doctor or nurse. […] Estrogen hormone therapy prevents bone loss and reduces the risk of fracture in the spine and hip. […] Alendronate, risedronate, zoledronic acid, teriparatide, and denosumab have been approved to treat osteoporosis in men. […] Other approved osteoporosis treatments for men are effective in men with low testosterone levels.

• #1 FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture | FDA

  https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-osteoporosis-postmenopausal-women-high-risk-fracture

  The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). […] Todays approval provides women with postmenopausal osteoporosis who are at high risk of fracture with a new treatment that will reduce this risk, said Hylton V. Joffe, M.D, M.M.Sc., director of the Center for Drug Evaluation and Researchs Division of Bone, Reproductive and Urologic Products. […] Evenity is a monoclonal antibody that blocks the effects of the protein sclerostin and works mainly by increasing new bone formation. […] The safety and efficacy of Evenity were demonstrated in two clinical trials involving a total of more than 11,000 women with postmenopausal osteoporosis. […] In the first trial, one year of treatment with Evenity lowered the risk of a new fracture in the spine (vertebral fracture) by 73% compared to placebo.

• #1 Osteoporosis Treatment: How to Choose the Right Medication

  https://www.bonehealthandosteoporosis.org/patients/treatment/

  A person with more severe bone loss or multiple broken bones may be recommended a different medicine than a person with less bone loss or no fractures. […] Your healthcare provider will consider other health problems you have when recommending a medicine. […] These factors can influence your treatment decision. No two people are the same. How well a medicine works, or what side effects it will have, can vary from one person to the next. […] Osteoporosis medications require a prescription from your healthcare provider. […] Most insurance companies cover medications administered by a healthcare professional in a medical office or hospital (such as a drug that is given by intravenous infusion). […] Types of medication given in a healthcare provider’s office or infusion center may include ibandronate (Boniva®), romosozumab (Evenity®), denosumab (Prolia®), and zoledronic acid (Reclast®). […] While many people shop online for their medicines to save money, the US Food and Drug Administration (FDA) warns that the practice is risky. […] The FDA provides guidelines to help people decide whether a website selling medicines is safe.

• #1

  https://www.healio.com/news/endocrinology/20220506/treatment-sequence-key-for-optimal-management-of-osteoporosis

  The mainstay of treatment that have been around the longest are bisphosphonates. […] Other than the bisphosphonates, we have estrogen, which is approved for prevention of osteoporosis, but not treatment. […] The evolving concepts of osteoanabolic therapy in the first-line setting are based on a few observations within the past 5 years that anabolic agents have a superior effect against fractures compared with antiresorptive therapies. […] Despite these advances, challenges and practical considerations associated with osteoporosis treatment remain. […] For patients with osteoporosis, the benefits of medication to reduce high risk for fracture outweigh the possible risks from treatment. […] The bottom line is guidelines are now matching the appropriate patient to the appropriate therapy.

• #1 Is Your Osteoporosis Treatment Working? Here’s How to Tell

  https://www.healthline.com/health/osteoporosis/is-osteoporosis-treatment-working

  If you have postmenopausal osteoporosis, youll likely need treatment. Medication, as well as diet and lifestyle strategies, can help strengthen your bones and reduce the risk of fractures. […] If you have postmenopausal osteoporosis, treatment is key to preventing fractures and long-term complications. This condition develops after a loss of bone mass, which makes your bones weak and prone to breaks. […] Some medications are used to prevent bone loss, while others help rebuild bone and boost bone mass. Ultimately, these treatments can help reduce the risk of broken bones. […] A bone density test can help determine whether your osteoporosis medication is working and helping to achieve your treatment goals. […] Here are some signs that your osteoporosis treatment is working: Your bone density has not decreased. You have not had further bone loss. You have not had any new fractures.

• #1 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/patients/treatment

  Overall, the common medically approved therapies have been shown to be safe and effective. There are potential side effects with any medication, and it is important to be aware of these. Each type of medication has different mechanisms of action and a distinct profile of side effects. For people at high risk of fracture, the benefit of a treatment in decreasing the risk of fracture far outweighs the rare occurrence of serious side effects. If you have any concerns, dont stop taking medication without discussing with your doctor. […] Like all medication, osteoporosis treatments can work only if they are taken properly. As reported for other chronic diseases, up to half of patients with osteoporosis stop their treatment after only one year. If you have been prescribed osteoporosis medication, you should keep in mind that by adhering to your treatment, you can benefit from larger increases in BMD, lose less bone mass, and reduce your fracture risk.

• #1 Osteoporosis: Symptoms, Causes and Treatment

  https://my.clevelandclinic.org/health/diseases/4443-osteoporosis

  Osteoporosis Treatment Find a Doctor and Specialists Osteoporosis Treatment for Children Find a Pediatric Doctor and Specialists Make an Appointment […] Your healthcare provider will suggest a combination of treatments that slow down your bone loss and strengthen your existing bone tissue. The most important part of treating osteoporosis is preventing bone fractures. […] The most common osteoporosis treatments include: Exercise: Regular exercise can strengthen your bones (and all the tissue connected to them, like your muscles, tendons and ligaments). Your provider might suggest weight-bearing exercise to strengthen your muscles and train your balance. […] Vitamin and mineral supplements: You might need over-the-counter or prescription calcium or vitamin D supplements. Your provider will tell you which type you need, how often you should take them and which dosage you’ll need.

• #1

  https://www.nhs.uk/conditions/osteoporosis/treatment/

  Biological medicines that can be used to treat osteoporosis include denosumab and romosozumab. […] Calcium is the main mineral found in bone, and having enough calcium as part of a healthy, balanced diet is important for maintaining healthy bones. […] HRT has also been shown to keep bones strong and reduce the risk of getting osteoporosis. If you already have osteoporosis it can strengthen your bones and reduce your risk of breaking a bone.

• #1

  https://link.springer.com/article/10.1007/s00198-021-05900-y

  All antifracture therapeutics treat but do not cure the disease. […] Ongoing monitoring and strategic interventions will be necessary if fractures are to be avoided. […] In addition to pharmacotherapy, adequate intake of calcium and vitamin D, avoidance of smoking and excessive alcohol intake, weight-bearing and resistance-training exercise, and fall prevention are included in the fracture prevention armamentarium. […] Current FDA-approved pharmacologic options for osteoporosis are as follows: Bisphosphonates (alendronate, ibandronate, risedronate, zoledronic acid), Estrogen-related therapy (ET/HT, raloxifene conjugated estrogens/ bazedoxifene), Parathyroid hormone analogs (teriparatide, abaloparatide), RANK-ligand inhibitor (denosumab), Sclerostin inhibitor (romosozumab), Calcitonin salmon.

• #1 Osteoporosis Medication and Medication Guidelines

  https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/

  Whatever medication you are prescribed to protect your bones, it won’t work without enough calcium and vitamin D. […] Falls are the leading cause of broken bones in older people. If you prevent falls, you prevent fractures. […] Many diseases and medical treatments can contribute to broken bones in older people, either by causing bone loss or by causing falls. […] Taking different medicines is not always easy to do properly. It may be hard to remember what each medicine is for, and how and when you should take each one.

• #1 How Osteoporosis Is Treated

  https://www.verywellhealth.com/effective-medications-for-treating-bone-loss-3522525

  With many osteoporosis medications, it’s recommended that people get adequate amounts of calcium and vitamin D. […] When osteoporosis causes fractures, more aggressive treatment may be needed to address the injury and improve the integrity of the bone. […] Vertebroplasty is a minimally invasive procedure that is used to treat compression fractures of the spine. […] Kyphoplasty is a similar procedure, except that a small balloon is first inserted into the compressed vertebrae and inflated. […] Both procedures can help reduce pain and restore mobility and stability.

• #1 Osteoporosis | Conditions | UCSF Health

  https://www.ucsfhealth.org/conditions/osteoporosis

  If your bone mass and risk factors put you at high risk for fracture, your doctor also may want you to take medication either to treat or prevent osteoporosis. There are many medications available. All have risks and benefits. Only you and your doctor can select which medication is right for you. […] A new treatment for osteoporosis spine fractures is called kyphoplasty. Kyphoplasty is a minimally invasive procedure, which means only tiny incisions are used. Through an incision, a small balloon is inserted into the collapsed bone to restore its shape. It is then filled with a substance that hardens and helps the bone expand. Long-term trials of this procedure are ongoing. […] No matter what your bone density is, all men should optimize their lifestyle to help prevent bone loss. This includes:

• #1 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/patients/treatment

  In addition to drug therapy, calcium and vitamin D supplements can be prescribed to ensure maximum effectiveness of your medication. You should be aware that attention to lifestyle factors (including risk factors, nutrition and exercise) must go hand in hand with any drug treatment prescribed. […] Practical and emotional support is important for anyone on osteoporosis treatment. This can be provided by health professionals, osteoporosis patient support groups, family and friends. Such support will help you manage your osteoporosis, and lessen any feelings of isolation and depression (experienced by many patients with severe osteoporosis). Contact your local osteoporosis society to find support and to ask about local support groups.

• #1

  https://link.springer.com/article/10.1007/s00198-021-05900-y

  Osteoporosis is the most common metabolic bone disease in the USA and the world. […] In appropriate patients, treatment with effective antifracture medication prevents fractures and improves outcomes. […] Osteoporosis detection, diagnosis, and treatment should be routine practice in all adult healthcare settings. […] Despite these advances, a disturbing gap persists in patient care. At-risk patients are often not screened to establish fracture probability and not educated about fracture prevention. […] The Clinicians Guide offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men aged 50 years and older. […] Current medications build bone and/or decrease bone breakdown and dramatically reduce incident fractures.

• #1

  https://link.springer.com/article/10.1007/s00198-021-05900-y

  Initiate antiresorptive therapy following discontinuation of denosumab, teriparatide, abaloparatide, or romosozumab. […] Denosumab is one of the most potent antiresorptive drugs available to treat osteoporosis because it directly inhibits osteoclast formation and causes apoptosis of mature osteoclasts. […] Denosumab reduces incidence of vertebral fractures by about 68% at 1 year, hip fractures by about 40% and non-vertebral fractures by about 20% at 3 years, with continued fracture reduction in studies extended to 5 years. […] Romosozumab reduces fractures and increases BMD at the lumbar spine and total hip more than placebo, alendronate, and teriparatide in postmenopausal women with low bone mass. […] The personal and economic costs of fractures are enormous. […] The osteoporosis treatment gap is truly a public health crisis, putting patients at risk for fragility fractures that cause avoidable suffering, disability, dependence, and premature death and cost millions in healthcare expenditures. […] Proven diagnostic technologies and bone-sparing therapies are widely available at low cost. […] However, these and other effective strategies are underutilized at every stage of healthcare delivery from inpatient to at-home and continuing care.

• #2 Osteoporosis – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/osteoporosis/diagnosis-treatment/drc-20351974

  Treatment recommendations are often based on an estimate of your risk of breaking a bone in the next 10 years using information such as the bone density test. If your risk isn’t high, treatment might not include medication and might focus instead on modifying risk factors for bone loss and falls. […] For both men and women at increased risk of broken bones, the most widely prescribed osteoporosis medications are bisphosphonates. […] Compared with bisphosphonates, denosumab (Prolia, Xgeva) produces similar or better bone density results and reduces the chance of all types of breaks. […] Estrogen, especially when started soon after menopause, can help maintain bone density. […] Raloxifene (Evista) mimics estrogen’s beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen.

• #2 Osteoporosis: A Review of Treatment Options

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5768298/

  The AACE/ACE recommends that pharmacological treatment should be initiated for: 1) patients with osteopenia or low bone mass and a history of fragility fracture at the hip or spine; 2) patients with a T-score of 2.5 or less in the lumbar spine, femoral neck, total hip, or 33% radius despite the absence of a fracture; or 3) patients with a T-score between 1.0 and 2.5 if the FRAX 10-year probability for a major osteoporotic fracture is greater than 20% or for a hip fracture is greater than 3%. […] The FDA-recommended dose of teriparatide is 20 mcg SC once daily in the thigh or abdomen. […] The AACE/ACE recommends that pharmacological treatment should be initiated for patients with a T-score of 2.5 or less in the lumbar spine, femoral neck, total hip, or 33% radius despite the absence of a fracture. […] The AACE/ACE recommends that pharmacological treatment should be initiated for patients with osteopenia or low bone mass and a history of fragility fracture at the hip or spine.

• #2 Osteoporosis Prevention and Treatment – OrthoInfo – AAOS

  https://orthoinfo.aaos.org/en/staying-healthy/osteoporosis-prevention/

  Osteoporosis Treatment, therapy […] Your physician can evaluate whether you have low bone density and determine the cause. Early treatment for osteoporosis is the most effective way to slow bone loss and prevent fractures. However, treatment programs after a fracture also are of value and may help to prevent future fractures. […] Most osteoporosis medications do not replace the bone you have already lost. However, they can help you prevent fractures and disability. […] The most commonly used medications slow bone loss by decreasing the amount of bone your body is reabsorbing, which improves the bone remodeling balance in the skeleton. This protects the architecture of the bone from worsening. […] You might need prescription medicines to treat osteoporosis if you are: A woman who has gone through menopause (your periods have stopped) A man over the age of 50 […] And you have 1 or more of the following conditions: A broken vertebra (spinal bone) A broken hip A T score (determined by a DEXA scan, or bone density test) of -2.5 or worse, measured in your hip or spine (a T score at this level means you have osteoporosis) A T score of -1 to -2.5, measured in your hip or spine (a T score at this level means you have osteopenia, or low bone mass, and are at risk for future fractures) […] Your doctor can use a computer scoring system developed by the World Health Organization to calculate your risk of breaking a bone. If your risk reaches a certain level and you have the conditions above, you will need prescription medicine. […] These are the main types of medications available: Bisphosphonates These medicines slow down bone loss, improving the overall quality of your bones by allowing the body to build new bone at a rate closer to how quickly it is lost. […] Selective estrogen receptor modulators (SERMs) The hormone estrogen helps build bone and maintain its strength and quality, and lower estrogen levels after menopause can contribute to osteoporosis. […] Calcitonin Calcitonin is a hormone that your body makes naturally and that helps control your calcium levels. […] Denosumab By preventing bone from breaking down, this monoclonal antibody (a drug that targets only certain cells in the body) can reduce the risk of fractures. […] Anabolic agents Teriparatide and abaloparatide contain a synthetic form of the natural human hormone PTH (parathyroid hormone). They work by stimulating the body to build new bone. […] Estrogen replacement therapy Estrogen replacement therapy is an effective option for preserving bone mass and preventing osteoporosis-related fractures in post-menopausal women (it is not appropriate for men or pre-menopausal women). […] Your doctor can help determine which of these medications is a good option for you. […] Current treatment methods focus more on preventing further bone loss, as we do not currently have reliable methods of restoring lost bone.

• #2 Osteoporosis Medication and Medication Guidelines

  https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/

  There are many medications available to treat osteoporosis and reduce the risk of fracture. They fall into two basic categories: antiresorptives and anabolics. Antiresorptive drugs include bisphosphonates (alendronate, ibandronate, risedronate, zoledronic acid), denosumab, calcitonin, estrogen/estrogen-progestin, an estrogen agonist/antagonist (raloxifene), and a tissue specific estrogen complex (estrogen/bazedoxifene). Antiresorptive drugs work by slowing the resorption or breakdown part of the remodeling cycle. Anabolics work by stimulating the formation part of the remodeling process. More bone is formed than is taken away. The result is stronger bone that is less likely to break. Teriparatide, a parathyroid hormone analog, abaloparatide, a parathyroid hormone-related protein analog, and romosozumab-aqqg, a sclerostin inhibitor, are the FDA-approved anabolic medicines available at this time.

• #2 Osteoporosis Treatment & Management: Approach Considerations, Pharmacologic Therapy, Dietary Measures

  https://emedicine.medscape.com/article/330598-treatment

  A 2008 literature review suggested that the use of „reminders plus education targeted to physicians and patients” can lead to increased BMD testing and greater use of osteoporosis medications. […] In patients who have experienced an osteoporotic fracture, the first goal of rehabilitation is to control pain. […] Currently, no treatment can completely reverse established osteoporosis. Early intervention can prevent osteoporosis in most people. For patients with established osteoporosis, medical intervention can halt its progression. […] Therapy should be individualized based on each patient’s clinical scenario, with the risks and benefits of treatment discussed between the clinician and patient. […] Bisphosphonates are the most commonly used agents for osteoporosis. Oral and intravenous options are available.

• #2 Building Strong Bones: A Comprehensive Guide to Osteoporosis Treatments: Institute of Spinal Disorders: Orthopedic Spine Surgery

  https://www.instituteofspinaldisorders.com/blog/building-strong-bones-a-comprehensive-guide-to-osteoporosis-treatments

  Alendronate (Fosamax), second-generation bisphosphonate, been seen to be most effective with patient with T-scores less than -2.5 or had vertebral fracture. […] Risedronate (Actonel) reduced the incidence of fractures of spine 41-49% after 3 years. […] Ibandronate(Boniva) is used for prevention and treatment of postmenopausal osteoporosis. […] Denosumab is used in the treatment of postmenopausal women for osteoporosis. […] Treatment with this medication has 68% decrease in new vertebral fractures in 12 months. […] Calcitonin reduces bone resorption and may slow bone loss. […] Teriparatide (Ferteo) treats osteoporosis in postmenopausal women and men who are at high risk of fractures. […] In conclusion, osteoporosis is a common condition that can have a significant impact on a person’s quality of life. While there is no cure for this disease, several treatments are available that can help to slow or even reverse the progression of bone loss. Medications, calcium and vitamin D supplements, exercise, healthy lifestyle choices, and fall prevention strategies can all be effective ways to treat osteoporosis.

• #2 Risks and management for treating osteoporosis

  https://australianprescriber.tg.org.au/articles/treating-osteoporosis-risks-and-management.html

  Bisphosphonates inhibit osteoclast activation and prevent bone resorption. […] Denosumab is a monoclonal antibody that reversibly inhibits bone resorption by reducing osteoclast formation and differentiation while increasing osteoclast apoptosis. […] Raloxifene is a selective oestrogen receptor modulator that reduces postmenopausal bone loss. […] Teriparatide is a synthetic form of parathyroid hormone that stimulates bone formation. […] Romosozumab is an antisclerostin monoclonal antibody that decreases bone resorption and increases bone formation. […] There is evidence to suggest that the treatment sequence may be important in managing osteoporosis. […] Repeat bone mineral density testing with dual-energy X-ray absorptiometry is useful to monitor a patients response to therapy. […] A combination of lifestyle and pharmacological strategies should be used to prevent fractures in older people, with effective screening tests available to identify those at higher risk.

• #2 How Osteoporosis Is Treated

  https://www.verywellhealth.com/effective-medications-for-treating-bone-loss-3522525

  Specific drugs, however, differ in their likelihood of preventing certain fracture types, how they are used, and some of the common side effects. […] Once they’re prescribed, you may not need to take bisphosphonates for the rest of your life. After three to five years of rebuilding bone, physicians may recommend that patients with a low risk of fracture stop taking their prescribed drug, according to a review by the U.S. Food and Drug Administration (FDA). […] Selective estrogen receptor modulators (SERMS) are interesting drugs in that they have estrogen-like effects on some tissues (such as bone) and anti-estrogen effects in others (such as breast tissue). […] Evista (raloxifene) is a SERM approved by the FDA to treat osteoporosis in women. It’s taken once a day in pill form. Evista slows bone loss and reduces the risk of spine (but not hip) fractures.

• #2 Osteoporosis Treatment & Management: Approach Considerations, Pharmacologic Therapy, Dietary Measures

  https://emedicine.medscape.com/article/330598-treatment

  Alendronate (Fosamax) is approved for the treatment of osteoporosis in men, in postmenopausal women, and in patients with glucocorticoid-induced osteoporosis. […] Risedronate reduced vertebral fractures by 41% and nonvertebral fractures by 39% over 3 years. […] Zoledronic acid (Reclast) is a once-yearly intravenous infusion approved for the treatment of osteoporosis in men, in postmenopausal women, and in patients with glucocorticoid-induced osteoporosis. […] Denosumab (Prolia) is a humanized monoclonal antibody directed against the receptor activator of the nuclear factor-kappa B ligand (RANKL), which is a key mediator of the resorptive phase of bone remodeling. […] Calcitonin salmon (Fortical, Miacalcin) is a hormone that decreases osteoclast activity, thereby impeding postmenopausal bone loss. […] Hormone replacement therapy (HRT) was once considered a first-line therapy for the prevention and treatment of osteoporosis in women. […] Strontium ranelate is approved for the treatment of osteoporosis in some countries in Europe. It reduces the risk of both spine and nonvertebral fractures.

• #2

  https://link.springer.com/article/10.1007/s00198-021-05900-y

  Initiate antiresorptive therapy following discontinuation of denosumab, teriparatide, abaloparatide, or romosozumab. […] Denosumab is one of the most potent antiresorptive drugs available to treat osteoporosis because it directly inhibits osteoclast formation and causes apoptosis of mature osteoclasts. […] Denosumab reduces incidence of vertebral fractures by about 68% at 1 year, hip fractures by about 40% and non-vertebral fractures by about 20% at 3 years, with continued fracture reduction in studies extended to 5 years. […] Romosozumab reduces fractures and increases BMD at the lumbar spine and total hip more than placebo, alendronate, and teriparatide in postmenopausal women with low bone mass. […] The personal and economic costs of fractures are enormous. […] The osteoporosis treatment gap is truly a public health crisis, putting patients at risk for fragility fractures that cause avoidable suffering, disability, dependence, and premature death and cost millions in healthcare expenditures. […] Proven diagnostic technologies and bone-sparing therapies are widely available at low cost. […] However, these and other effective strategies are underutilized at every stage of healthcare delivery from inpatient to at-home and continuing care.

• #2 Osteoporosis: Diagnosis, Treatment, and Steps to Take

  https://www.niams.nih.gov/health-topics/osteoporosis/diagnosis-treatment-and-steps-to-take

  The goals for treating osteoporosis are to slow or stop bone loss and to prevent fractures. Your health care provider may recommend: […] Your doctor may prescribe medications for osteoporosis. The U.S. Food and Drug Administration (FDA) has approved the following medications for the prevention or treatment of osteoporosis: […] Medications can cause side effects. If you have questions about your medications, talk to your doctor or pharmacist. […] Bisphosphonates. Several bisphosphonates are approved to help preserve bone density and strength and to treat osteoporosis. This type of drug works by slowing down bone loss, which can lower the chance of fractures. […] Calcitonin. This medication is made from a hormone from the thyroid gland and is approved for the treatment of osteoporosis in postmenopausal women who cannot take or tolerate other medications for osteoporosis.

• #2 Osteoporosis treatment options – myDr.com.au

  https://mydr.com.au/seniors-health/osteoporosis-treatment-options/

  Calcium supplements may be recommended if you take osteoporosis medicines and you get less than 1300 mg per day of calcium from your diet. […] Your maximum bone density is largely determined early in life. However, even if you have developed osteoporosis, high-impact weight-bearing exercise and progressive resistance exercises (strength training, or weight lifting) can help maintain your existing bone density and even improve on it. […] Bisphosphonates are a type of medicine that can slow bone loss, improve bone density and reduce the risk of fractures. […] Denosumab (brand name Prolia) is a monoclonal antibody medicine that slows down the amount of bone that is broken down (resorbed) in the normal bone renewal (turnover) process. […] Hormone replacement therapy (HRT) can also help prevent bone loss, improve bone density and reduce fracture rates when given around the time of menopause or after menopause.

• #2 Patient education: Osteoporosis prevention and treatment (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/osteoporosis-prevention-and-treatment-beyond-the-basics

  Calcitonin — Calcitonin is a hormone produced by the thyroid gland that, together with parathyroid hormone (PTH), helps to regulate calcium concentrations in the body. Calcitonin is no longer used to treat osteoporosis, because other available options (eg, bisphosphonates) are more effective for the prevention of bone loss and reduction of fracture risk. […] Anabolic agents — Anabolic agents are usually only recommended for people with severe osteoporosis. Anabolic agents are unique osteoporosis drugs in that they work by stimulating bone formation. […] Monitoring response to treatment […] If you take medication to prevent or treat osteoporosis, your doctor will monitor you to see how well it is working.

• #2 Osteoporosis: Diagnosis, Treatment, and Steps to Take

  https://www.niams.nih.gov/health-topics/osteoporosis/diagnosis-treatment-and-steps-to-take

  Estrogen agonist/antagonist. An estrogen agonist/antagonist, also known as a selective estrogen receptor modulator (SERM), and tissue-selective estrogen complex (TSEC), are both approved to treat and prevent osteoporosis in postmenopausal women. […] Estrogen and hormone therapy. Estrogen and combined estrogen and progestin (hormone therapy) are approved to prevent osteoporosis and fractures in postmenopausal women. […] Parathyroid hormone (PTH) analog and parathyroid hormone related-protein (PTHrP) analog. PTH is a form of human parathyroid hormone that increases bone mass and is approved for postmenopausal women and men with osteoporosis who are at high risk for fracture. […] RANK ligand (RANKL) inhibitor. This is an inhibitor that helps slow down bone loss and is approved to treat osteoporosis in: […] Sclerostin inhibitor. This is a medication that treats severe osteoporosis by blocking the effect of a protein, and helps the body increase new bone formation as well as slows down bone loss.

• #2 Osteoporosis : Strategies for Osteoporosis Management in a Primary Care Setting

  https://www.hopkinsarthritis.org/arthritis-info/osteoporosis-info/osteoporosis-prevention-and-treatment/

  Primary health care should routinely address bone health. For newly menopausal women, estrogen replacement was the standard of practice to prevent bone loss. Thus, hormone replacement therapy is not currently recommended for either prevention or treatment of osteoporosis in postmenopausal women. Testosterone replacement for hypogonadal men preserves bone mass. Osteoporosis Management is evolving. There is consensus that calcium and vitamin D intake is needed to increase bone mass. Bisphosphonates are corner stone of therapy for prevention and treatment of osteoporosis and have been shown to reduce vertebral and non-vertebral fractures. Calcitonin has also been shown to reduce vertebral fractures. Forteo lowers the risk of fractures in postmenopausal women with osteoporosis. In a randomized trial of 1,637 postmenopausal women with prior vertebral fractures, women who took Forteo had a 65% lower risk of new vertebral fractures and a 53% lower risk of new nonvertebral fractures, compared with women who received placebo. Prolia is approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture. In a 3 year trial of post-menopausal women with osteoporosis, denosumab therapy reduced hip fracture by 40% and vertebral fractures by 68%. Weight-bearing exercise has been shown to increase bone mass, strengthen muscle, and reduce the risk of falls. Is it reasonable to implement an osteoporosis treatment program in the setting of a recent fracture? Our experience to date is yes. The Womens Health Initiative, a large randomized trial of hormone replacement in post-menopausal women, showed an increased risk of stroke, breast cancer and thrombosis associated with hormone replacement therapy. Selective estrogen receptor modulators such as raloxifene 60 mg daily are also available for treatment and prevention of post-menopausal osteoporosis.

• #2 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/patients/treatment

  There are two main types of treatment: anti-resorptive agents reduce bone destruction and therefore preserve bone mineral density (BMD), while anabolic agents stimulate bone formation, thereby increasing BMD. […] Medically approved drug therapies for the treatment of osteoporosis and prevention of fractures include: Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid), Raloxifene and bazedoxifene, Teriparatide and abaloparatide, Denosumab, Romosozumab, Menopausal Hormone Therapy (MHT)*. […] Not all of these drugs are available in every country. […] MHT (oestrogen with or without progestin) is not a primary treatment for osteoporosis but has been shown to increase BMD and lower fracture risk in women after menopause. MHT is only recommended for younger postmenopausal women for the treatment of menopausal symptoms, with no contra-indications to its use, and for a limited period of time of approximately 10 years.

• #2 Osteoporosis: A Review of Treatment Options

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5768298/

  The AACE/ACE recommends denosumab as first-line therapy for patients at high risk of fracture and for patients who are unable to use oral therapy. […] The AACE/ACE suggests the use of teriparatide for initial PMO treatment in those with prior fragility fractures or with high fracture risk and for those who are unable to take oral therapy. […] The AACE/ACE recommends bisphosphonates, excluding ibandronate, as a first-line option for the prevention and/or treatment of osteoporosis in postmenopausal women, men, and/or GIO patients. […] Raloxifene should be considered in women with an increased risk of vertebral fractures who may be at risk for developing breast cancer. […] Calcitonin is not considered first-line treatment for osteoporosis. […] The AACE/ACE recommends treatment with an antiresorptive agent immediately following teriparatide therapy to avoid bone density decline.

• #2 A new therapy for osteoporosis: Romosozumab – Harvard Health

  https://www.health.harvard.edu/blog/a-new-therapy-for-osteoporosis-romosozumab-2019071717339

  Osteoporosis is a condition in which bones become porous (less dense) and weaker. […] A new drug called romosozumab is getting a lot of attention. […] There are currently several medications available to treat osteoporosis. […] Now, for the first time since 2010, a new class of medication is available to treat osteoporosis. Romosozumab (Evenity) is in a class called sclerostin inhibitors and is considered an anabolic agent. […] Romosozumab is approved by the FDA to treat osteoporosis in women who have completed menopause and are at high risk for fracture. […] The medication is injected once a month using two separate prefilled syringes for a full dose. […] Two large trials in The New England Journal of Medicine have looked at this new medication. […] Based on this research, a year of romosozumab therapy, followed by an anti-resorptive agent like alendronate, zoledronate, or denosumab, is a new and effective option for certain women to prevent fractures related to osteoporosis. […] We do not yet have long-term data on romosozumab. But a dual effect (increasing bone formation and decreasing bone resorption) makes it a welcome addition to available treatments for osteoporosis at least for postmenopausal women at high risk for fracture.

• #2 Best And Safest Treatment For Osteoporosis

  https://www.getwellen.com/well-guide/what-is-the-best-and-safest-treatment-for-osteoporosis

  Medication is standard for treating osteoporosis, although there are lifestyle changes you should make, too. […] Depending on the severity of the osteoporosis, your medical history and your history of fractures, your doctor might recommend osteoporosis medication to prevent further bone loss. Osteoporosis cannot be cured, but these medications can help with reduction of fracture risk and improving your bone health. Some osteoporosis medications slow or prevent bone loss, while others can help build new bone. […] Often, patients with osteoporosis are first given a class of medications called bisphosphonates. These drugs inhibit an enzyme responsible for bone resorption (the breakdown of bone tissue) and effectively prevent and treat osteoporosis. […] Denosumab (Prolia) is a different type of medication from a bisphosphonate, called a RANK ligand inhibitor. This type of medication reduces bone resorption and turnover.

• #2

  https://www.healio.com/news/endocrinology/20220506/treatment-sequence-key-for-optimal-management-of-osteoporosis

  Recent research indicates that the sequence of osteoporosis treatment is key. […] Findings from the ARCH trial showed the largest BMD gains after 1 year of romosozumab. […] It is now incorporated into many practice guidelines that we should consider osteoporosis a lifelong disease, and just as with any other lifelong chronic disease, there is no temporary treatment. […] Better physician education is also needed. […] Any treatment for osteoporosis is better than none, but we need to recognize that some treatments are better than others, and we now know that the sequence of therapy is so important.

• #2 Osteoporosis treatment options – myDr.com.au

  https://mydr.com.au/seniors-health/osteoporosis-treatment-options/

  Raloxifene has been shown to reduce bone loss after menopause, and can reduce the risk of backbone (spine) fractures. […] Teriparatide (brand name Forteo) is a synthetic version of human parathyroid hormone. It increases bone formation (it is the only osteoporosis medicine that does), thus increasing bone density, and reduces the risk of fractures. […] Your doctor will want to see you regularly if you have osteoporosis, to check on your condition and adjust your treatments if necessary. […] Bone mineral density (BMD) scans can help show whether osteoporosis treatment is working. […] You may want to join an osteoporosis support group to meet and talk with other people living with osteoporosis.

• #2 Denosumab (Prolia) – drug treatment for osteoporosis

  https://theros.org.uk/information-and-support/osteoporosis/treatment/denosumab/

  While there’s no clear way to prove for certain that your treatment is working, research has shown that denosumab does lower the risk of broken bones. […] Denosumab wears off quickly and stops helping your bones when you stop taking it. […] It can help to reduce your risk of broken bones, including in your hips and spine. […] The benefits of the drug wear off very quickly if you stop having it.

• #2 Osteoporosis treatment: Medications can help

  https://www.mayoclinic.org/diseases-conditions/osteoporosis/in-depth/osteoporosis-treatment/art-20046869

  Osteoporosis treatment may involve medicines along with lifestyle change. […] If you’re undergoing osteoporosis treatment, you’re taking a step in the right direction for your bone health. […] Bisphosphonates are often the first choice for osteoporosis treatment. […] Another common osteoporosis medicine is denosumab (Prolia). […] Research shows that there could be a high risk of spinal fractures after stopping denosumab, so it’s important that you take it consistently. […] The risk of developing atypical femoral fracture or osteonecrosis of the jaw tends to increase the longer you take bisphosphonates. […] Estrogen, sometimes paired with progestin, was once commonly used to treat osteoporosis. […] Raloxifene (Evista) mimics estrogen’s beneficial effects on bone density in postmenopausal women, without some of the risks associated with estrogen. […] Most osteoporosis medicines work by reducing the rate at which your bones break down. […] Bone-building medicines include: Teriparatide (Forteo), Abaloparatide (Tymlos), Romosozumab (Evenity). […] Don’t rely entirely on medicines as the only treatment for your osteoporosis.

• #2 Osteoporosis Medication and Medication Guidelines

  https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/

  Like any medication, osteoporosis drugs can only work if they are taken exactly as prescribed. […] The important thing is to take your medicine and take it consistently. […] With antiresorptive medicines, the goal of treatment is to prevent further bone loss and reduce the risk of fractures. […] You know the drug is working when your bone density stays the same or improves and you have no additional broken bones. […] Romosozumab-aqqg, Teriparatide and Abaloparatide are the only drugs for osteoporosis that have a defined treatment length. […] When a patient responds well to bisphosphonate therapy, many healthcare providers will consider a “bisphosphonate drug holiday” during which the patient takes a break from treatment. […] At the doses used for osteoporosis, AFF and ONJ are very rare. On the other hand, fragility fractures from osteoporosis are very common.

• #2 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/patients/treatment

  In addition to drug therapy, calcium and vitamin D supplements can be prescribed to ensure maximum effectiveness of your medication. You should be aware that attention to lifestyle factors (including risk factors, nutrition and exercise) must go hand in hand with any drug treatment prescribed. […] Practical and emotional support is important for anyone on osteoporosis treatment. This can be provided by health professionals, osteoporosis patient support groups, family and friends. Such support will help you manage your osteoporosis, and lessen any feelings of isolation and depression (experienced by many patients with severe osteoporosis). Contact your local osteoporosis society to find support and to ask about local support groups.

• #2

  https://link.springer.com/article/10.1007/s00198-021-05900-y

  All antifracture therapeutics treat but do not cure the disease. […] Ongoing monitoring and strategic interventions will be necessary if fractures are to be avoided. […] In addition to pharmacotherapy, adequate intake of calcium and vitamin D, avoidance of smoking and excessive alcohol intake, weight-bearing and resistance-training exercise, and fall prevention are included in the fracture prevention armamentarium. […] Current FDA-approved pharmacologic options for osteoporosis are as follows: Bisphosphonates (alendronate, ibandronate, risedronate, zoledronic acid), Estrogen-related therapy (ET/HT, raloxifene conjugated estrogens/ bazedoxifene), Parathyroid hormone analogs (teriparatide, abaloparatide), RANK-ligand inhibitor (denosumab), Sclerostin inhibitor (romosozumab), Calcitonin salmon.

• #2 Guide | Physical Therapy Guide to Osteoporosis | Choose PT

  https://www.choosept.com/guide/physical-therapy-guide-osteoporosis

  Your physical therapist can develop a specific program based on your individual needs to help improve your overall bone health, keep your bones healthy, and help you avoid fracture. […] Healthy bone is built and maintained through a healthy lifestyle. Your physical therapist will teach you specific exercises to meet your particular needs. […] If you are diagnosed with osteoporosis or low bone density, your physical therapist will work with you to: Build bone or lessen the amount of bone loss at areas most vulnerable to fracture through exercisehip, spine, shoulder, arms. […] Conservative treatment of a fracture includes bed rest and appropriate pain treatment. Your physical therapist will work with you to: Decrease your pain through positioning and other pain-relieving modalities. […] Osteoporosis can be prevented by building adequate bone density through childhood, adolescence, and early adulthood. Building strong bones requires an adequate intake of calcium and vitamin D, and regular exercise.

• #2 Osteoporosis Treatment & Management: Approach Considerations, Pharmacologic Therapy, Dietary Measures

  https://emedicine.medscape.com/article/330598-treatment

  A clinical practice guideline from the American College of Physicians on treatment to prevent fractures in men and women with low bone density or osteoporosis includes six recommendations: two strong recommendations, based on high- or moderate-quality evidence, and four weak ones, based on low-quality evidence. The two strong recommendations are as follows: […] Clinicians should offer pharmacologic treatment to women with known osteoporosis to reduce the risk for hip and vertebral fractures; alendronate, risedronate, zoledronic acid, or denosumab may be used. […] In postmenopausal women, estrogen or estrogen plus progestogen or raloxifene should not be used for the treatment of osteoporosis. […] Nonpharmacologic preventive measures include modification of general lifestyle factors, such as increasing weight-bearing and muscle-strengthening exercise, which epidemiologic studies have linked to lower fracture rates, and ensuring optimum calcium and vitamin D intake as adjunct to active antifracture therapy.

• #2

  https://www.advocatehealth.com/health-services/orthopedic-center/bone-health/osteoporosis-treatment

  Osteoporosis treatment is essential to ensure you stay healthy and avoid complications and bone fractures from osteoporosis. Our team will evaluate your condition, discuss your test results and develop a personalized osteoporosis treatment plan that will help improve your mobility and minimize your osteoporosis symptoms. […] For nonsurgical osteoporosis treatment, your doctor may recommend the following to improve symptoms and avoid injuries: Exercise to increase strength, muscle mass, coordination and balance plus relieve any pain, Instruction in correct body mechanics for work and daily activities to avoid excessive strain to the spine that can lead to fractures, Physical therapy, Education to prevent falls and avoid fractures, Medications for pain or to treat osteoporosis, Calcium or vitamin D supplements, Weight loss counseling. […] For more advanced osteoporosis, additional osteoporosis treatment may also include spinal surgery. Methods may include: Kyphoplasty, Spinal fusion, Spinal nerve block, Spinal stabilization, Vertebroplasty.

• #2 Treatment | International Osteoporosis Foundation

  https://www.osteoporosis.foundation/health-professionals/treatment

  Each class of medications has different mechanisms of action and its distinct profile of side effects. […] For people at high risk of fracture, the benefit of a treatment in decreasing the risk of fracture far outweigh the risk of serious side effects. […] Practical and emotional support is important for a person on osteoporosis treatment. This can be provided by health professionals, osteoporosis patient support groups, family and friends. Such support is of great assistance in helping people manage their osteoporosis, and in lessening the feelings of isolation and depression experienced by many patients with severe osteoporosis. […] IOF and the Bone Health and Osteoporosis Foundation (BHOF) have developed a clear and simple tool aiming to help primary care providers initiate a dialogue with their patients about osteoporosis and fracture risk. It is intended to be used during medical consultations to improve patients understanding of their condition and provide them with essential information about anti-osteoporosis medications and their relative risks and benefits.

• #2

  https://www.healio.com/news/endocrinology/20220506/treatment-sequence-key-for-optimal-management-of-osteoporosis

  Osteoporosis is a common disease that remains significantly underdiagnosed and undertreated. […] There is no lack of treatment options, as several new therapies have been approved during the past few years that have added to the arsenal of therapeutic options for osteoporosis. […] The American Association of Clinical Endocrinology [AACE] and the Endocrine Society guidelines recommend treatment with osteoanabolic medications for patients who are at very high risk for fracture based on data showing strong efficacy against vertebral and nonvertebral fractures as a class, including hip fractures. […] The other class of agents, osteoanabolics, builds new bone. These include teriparatide, abaloparatide (Tymlos, Radius Health) and romosozumab-aqqg (Evenity, Amgen). […] The currently available therapeutic options for the prevention and treatment of osteoporosis are vast.

• #3 Osteoporosis: A Review of Treatment Options

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5768298/

  The AACE/ACE recommends that pharmacological treatment should be initiated for: 1) patients with osteopenia or low bone mass and a history of fragility fracture at the hip or spine; 2) patients with a T-score of 2.5 or less in the lumbar spine, femoral neck, total hip, or 33% radius despite the absence of a fracture; or 3) patients with a T-score between 1.0 and 2.5 if the FRAX 10-year probability for a major osteoporotic fracture is greater than 20% or for a hip fracture is greater than 3%. […] The FDA-recommended dose of teriparatide is 20 mcg SC once daily in the thigh or abdomen. […] The AACE/ACE recommends that pharmacological treatment should be initiated for patients with a T-score of 2.5 or less in the lumbar spine, femoral neck, total hip, or 33% radius despite the absence of a fracture. […] The AACE/ACE recommends that pharmacological treatment should be initiated for patients with osteopenia or low bone mass and a history of fragility fracture at the hip or spine.

• #3 Prolia® (denosumab) for Postmenopausal Osteoporosis

  https://www.prolia.com/

  Prolia is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well. […] Prolia is a prescription medicine used to increase bone mass in men with osteoporosis who are at high risk for fracture. […] Prolia is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture. […] Prolia is a prescription medicine used to treat bone loss in men who are at high risk for fracture receiving certain treatments for prostate cancer that has not spread to other parts of the body. […] Prolia is a prescription medicine used to treat bone loss in women who are at high risk for fracture receiving certain treatments for breast cancer that has not spread to other parts of the body.

• #3 Osteoporosis: A Review of Treatment Options

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5768298/

  The AACE/ACE recommends denosumab as first-line therapy for patients at high risk of fracture and for patients who are unable to use oral therapy. […] The AACE/ACE suggests the use of teriparatide for initial PMO treatment in those with prior fragility fractures or with high fracture risk and for those who are unable to take oral therapy. […] The AACE/ACE recommends bisphosphonates, excluding ibandronate, as a first-line option for the prevention and/or treatment of osteoporosis in postmenopausal women, men, and/or GIO patients. […] Raloxifene should be considered in women with an increased risk of vertebral fractures who may be at risk for developing breast cancer. […] Calcitonin is not considered first-line treatment for osteoporosis. […] The AACE/ACE recommends treatment with an antiresorptive agent immediately following teriparatide therapy to avoid bone density decline.

• #3 Osteoporosis : Strategies for Osteoporosis Management in a Primary Care Setting

  https://www.hopkinsarthritis.org/arthritis-info/osteoporosis-info/osteoporosis-prevention-and-treatment/

  Primary health care should routinely address bone health. For newly menopausal women, estrogen replacement was the standard of practice to prevent bone loss. Thus, hormone replacement therapy is not currently recommended for either prevention or treatment of osteoporosis in postmenopausal women. Testosterone replacement for hypogonadal men preserves bone mass. Osteoporosis Management is evolving. There is consensus that calcium and vitamin D intake is needed to increase bone mass. Bisphosphonates are corner stone of therapy for prevention and treatment of osteoporosis and have been shown to reduce vertebral and non-vertebral fractures. Calcitonin has also been shown to reduce vertebral fractures. Forteo lowers the risk of fractures in postmenopausal women with osteoporosis. In a randomized trial of 1,637 postmenopausal women with prior vertebral fractures, women who took Forteo had a 65% lower risk of new vertebral fractures and a 53% lower risk of new nonvertebral fractures, compared with women who received placebo. Prolia is approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture. In a 3 year trial of post-menopausal women with osteoporosis, denosumab therapy reduced hip fracture by 40% and vertebral fractures by 68%. Weight-bearing exercise has been shown to increase bone mass, strengthen muscle, and reduce the risk of falls. Is it reasonable to implement an osteoporosis treatment program in the setting of a recent fracture? Our experience to date is yes. The Womens Health Initiative, a large randomized trial of hormone replacement in post-menopausal women, showed an increased risk of stroke, breast cancer and thrombosis associated with hormone replacement therapy. Selective estrogen receptor modulators such as raloxifene 60 mg daily are also available for treatment and prevention of post-menopausal osteoporosis.

• #3 Osteoporosis Medication and Medication Guidelines

  https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/

  Although there is no cure for osteoporosis, the U.S. Food and Drug Administration (FDA) has approved medicines to prevent, slow, or stop its progress. Taking a prescribed osteoporosis medicine, along with getting enough calcium, vitamin D and regular exercise, can help reduce the risk of broken bones (also called fractures) due to osteoporosis. […] Available therapies for osteoporosis are effective in preventing osteoporosis and can reduce fracture risk by more than 50%. […] The goal of osteoporosis therapy is to try to restore the balance of resorption and formation. It can be done by slowing resorption through use of antiresorptive medication or by promoting bone formation using anabolic medication. By doing so, these therapies lower the risk for fractures, which is the goal of treatment.

• #4 Risks and management for treating osteoporosis

  https://australianprescriber.tg.org.au/articles/treating-osteoporosis-risks-and-management.html

  Osteoporosis, osteopenia and minimal trauma fractures are becoming increasingly common in the ageing population. […] Antiresorptive drugs such as bisphosphonates and denosumab remain first-line treatment options for osteoporosis. […] Raloxifene may be considered in women who do not tolerate first-line antiresorptive drugs. […] Romosozumab is a new anabolic treatment for osteoporosis and, together with teriparatide, is subsidised as second-line therapy for individuals with severe disease and multiple fractures. […] Pharmacotherapy is indicated for individuals with a significantly increased risk of fractures. First-line treatment is available under the Pharmaceutical Benefits Scheme (PBS) for: those 50 years of age and over who have sustained a minimal trauma fracture; those 70 years of age and over with established osteoporosis; those who require long-term corticosteroids (minimum three months) on at least 7.5 mg of prednisolone or equivalent per day.

Zobacz więcej